Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles

Emi Yamano, Masahiro Sugimoto, Akiyoshi Hirayama, Satoshi Kume, Masanori Yamato, Guanghua Jin, Seiki Tajima, Nobuhito Goda, Kazuhiro Iwai, Sanae Fukuda, Kouzi Yamaguti, Hirohiko Kuratsune, Tomoyoshi Soga, Yasuyoshi Watanabe, Yosky Kataoka

    Research output: Contribution to journalArticle

    27 Citations (Scopus)

    Abstract

    Chronic fatigue syndrome (CFS) is a persistent and unexplained pathological state characterized by exertional and severely debilitating fatigue, with/without infectious or neuropsychiatric symptoms, lasting at least 6 consecutive months. Its pathogenesis remains incompletely understood. Here, we performed comprehensive metabolomic analyses of 133 plasma samples obtained from CFS patients and healthy controls to establish an objective diagnosis of CFS. CFS patients exhibited significant differences in intermediate metabolite concentrations in the tricarboxylic acid (TCA) and urea cycles. The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls, yielding area under the receiver operating characteristic curve values of 0.801 (95% confidential interval [CI]: 0.711-0.890, P < 0.0001) and 0.750 (95% CI: 0.584-0.916, P = 0.0069) for training (n = 93) and validation (n = 40) datasets, respectively. These findings provide compelling evidence that a clinical diagnostic tool could be developed for CFS based on the ratios of metabolites in plasma.

    Original languageEnglish
    Article number34990
    JournalScientific Reports
    Volume6
    DOIs
    Publication statusPublished - 2016 Oct 11

    Fingerprint

    Chronic Fatigue Syndrome
    Citric Acid Cycle
    Urea
    Citrulline
    Ornithine
    Metabolomics
    Pyruvic Acid
    ROC Curve
    Fatigue

    ASJC Scopus subject areas

    • General

    Cite this

    Yamano, E., Sugimoto, M., Hirayama, A., Kume, S., Yamato, M., Jin, G., ... Kataoka, Y. (2016). Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Scientific Reports, 6, [34990]. https://doi.org/10.1038/srep34990

    Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. / Yamano, Emi; Sugimoto, Masahiro; Hirayama, Akiyoshi; Kume, Satoshi; Yamato, Masanori; Jin, Guanghua; Tajima, Seiki; Goda, Nobuhito; Iwai, Kazuhiro; Fukuda, Sanae; Yamaguti, Kouzi; Kuratsune, Hirohiko; Soga, Tomoyoshi; Watanabe, Yasuyoshi; Kataoka, Yosky.

    In: Scientific Reports, Vol. 6, 34990, 11.10.2016.

    Research output: Contribution to journalArticle

    Yamano, E, Sugimoto, M, Hirayama, A, Kume, S, Yamato, M, Jin, G, Tajima, S, Goda, N, Iwai, K, Fukuda, S, Yamaguti, K, Kuratsune, H, Soga, T, Watanabe, Y & Kataoka, Y 2016, 'Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles', Scientific Reports, vol. 6, 34990. https://doi.org/10.1038/srep34990
    Yamano E, Sugimoto M, Hirayama A, Kume S, Yamato M, Jin G et al. Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Scientific Reports. 2016 Oct 11;6. 34990. https://doi.org/10.1038/srep34990
    Yamano, Emi ; Sugimoto, Masahiro ; Hirayama, Akiyoshi ; Kume, Satoshi ; Yamato, Masanori ; Jin, Guanghua ; Tajima, Seiki ; Goda, Nobuhito ; Iwai, Kazuhiro ; Fukuda, Sanae ; Yamaguti, Kouzi ; Kuratsune, Hirohiko ; Soga, Tomoyoshi ; Watanabe, Yasuyoshi ; Kataoka, Yosky. / Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. In: Scientific Reports. 2016 ; Vol. 6.
    @article{a5c63f78e5254156a799582b8b6577a2,
    title = "Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles",
    abstract = "Chronic fatigue syndrome (CFS) is a persistent and unexplained pathological state characterized by exertional and severely debilitating fatigue, with/without infectious or neuropsychiatric symptoms, lasting at least 6 consecutive months. Its pathogenesis remains incompletely understood. Here, we performed comprehensive metabolomic analyses of 133 plasma samples obtained from CFS patients and healthy controls to establish an objective diagnosis of CFS. CFS patients exhibited significant differences in intermediate metabolite concentrations in the tricarboxylic acid (TCA) and urea cycles. The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls, yielding area under the receiver operating characteristic curve values of 0.801 (95{\%} confidential interval [CI]: 0.711-0.890, P < 0.0001) and 0.750 (95{\%} CI: 0.584-0.916, P = 0.0069) for training (n = 93) and validation (n = 40) datasets, respectively. These findings provide compelling evidence that a clinical diagnostic tool could be developed for CFS based on the ratios of metabolites in plasma.",
    author = "Emi Yamano and Masahiro Sugimoto and Akiyoshi Hirayama and Satoshi Kume and Masanori Yamato and Guanghua Jin and Seiki Tajima and Nobuhito Goda and Kazuhiro Iwai and Sanae Fukuda and Kouzi Yamaguti and Hirohiko Kuratsune and Tomoyoshi Soga and Yasuyoshi Watanabe and Yosky Kataoka",
    year = "2016",
    month = "10",
    day = "11",
    doi = "10.1038/srep34990",
    language = "English",
    volume = "6",
    journal = "Scientific Reports",
    issn = "2045-2322",
    publisher = "Nature Publishing Group",

    }

    TY - JOUR

    T1 - Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles

    AU - Yamano, Emi

    AU - Sugimoto, Masahiro

    AU - Hirayama, Akiyoshi

    AU - Kume, Satoshi

    AU - Yamato, Masanori

    AU - Jin, Guanghua

    AU - Tajima, Seiki

    AU - Goda, Nobuhito

    AU - Iwai, Kazuhiro

    AU - Fukuda, Sanae

    AU - Yamaguti, Kouzi

    AU - Kuratsune, Hirohiko

    AU - Soga, Tomoyoshi

    AU - Watanabe, Yasuyoshi

    AU - Kataoka, Yosky

    PY - 2016/10/11

    Y1 - 2016/10/11

    N2 - Chronic fatigue syndrome (CFS) is a persistent and unexplained pathological state characterized by exertional and severely debilitating fatigue, with/without infectious or neuropsychiatric symptoms, lasting at least 6 consecutive months. Its pathogenesis remains incompletely understood. Here, we performed comprehensive metabolomic analyses of 133 plasma samples obtained from CFS patients and healthy controls to establish an objective diagnosis of CFS. CFS patients exhibited significant differences in intermediate metabolite concentrations in the tricarboxylic acid (TCA) and urea cycles. The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls, yielding area under the receiver operating characteristic curve values of 0.801 (95% confidential interval [CI]: 0.711-0.890, P < 0.0001) and 0.750 (95% CI: 0.584-0.916, P = 0.0069) for training (n = 93) and validation (n = 40) datasets, respectively. These findings provide compelling evidence that a clinical diagnostic tool could be developed for CFS based on the ratios of metabolites in plasma.

    AB - Chronic fatigue syndrome (CFS) is a persistent and unexplained pathological state characterized by exertional and severely debilitating fatigue, with/without infectious or neuropsychiatric symptoms, lasting at least 6 consecutive months. Its pathogenesis remains incompletely understood. Here, we performed comprehensive metabolomic analyses of 133 plasma samples obtained from CFS patients and healthy controls to establish an objective diagnosis of CFS. CFS patients exhibited significant differences in intermediate metabolite concentrations in the tricarboxylic acid (TCA) and urea cycles. The combination of ornithine/citrulline and pyruvate/isocitrate ratios discriminated CFS patients from healthy controls, yielding area under the receiver operating characteristic curve values of 0.801 (95% confidential interval [CI]: 0.711-0.890, P < 0.0001) and 0.750 (95% CI: 0.584-0.916, P = 0.0069) for training (n = 93) and validation (n = 40) datasets, respectively. These findings provide compelling evidence that a clinical diagnostic tool could be developed for CFS based on the ratios of metabolites in plasma.

    UR - http://www.scopus.com/inward/record.url?scp=84991510882&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84991510882&partnerID=8YFLogxK

    U2 - 10.1038/srep34990

    DO - 10.1038/srep34990

    M3 - Article

    C2 - 27725700

    AN - SCOPUS:84991510882

    VL - 6

    JO - Scientific Reports

    JF - Scientific Reports

    SN - 2045-2322

    M1 - 34990

    ER -